Skip to content

Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes

Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes in CHNS

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03259321
Enrollment
15100
Registered
2017-08-23
Start date
1989-01-01
Completion date
2012-12-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes

Keywords

Fish, Polyunsaturated fatty acids, CHNS

Brief summary

The role of fishery diet and polyunsaturated fatty acids (PUFA) in the development of type 2 diabetes (T2D) is heavily debated but evidence from large populations in China is scant. The investigators aim to use data from the China Health and Nutrition Survey (CHNS) to assess the long-term association between fish, PUFA intake and T2D risk.

Detailed description

The role of fishery diet and polyunsaturated fatty acids (PUFA) in the development of T2D is heavily debated but evidence from large populations in China is still lacking. The investigators aim to utilize data from China Health and Nutrition Survey (CHNS, 1997-2011). The investigators will calculate cumulative means of fish and PUFA intake based on 3-day food records in each wave. Sex-specific Cox regression models will be used to estimate relative risk of T2D. Results from this work will provide epidemiological evidence for improving recommendations on fish and PUFA intake for Chinese in dietary guidelines.

Interventions

None listed

Sponsors

National Institute of Health and Nutrition
CollaboratorOTHER_GOV
Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged ≥20 with complete data on diet and follow-up time

Exclusion criteria

* Missing information for Type 2 diabetes * Type 2 diabetes * Cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Type 2 diabetesFrom entry into the study (baseline: 1997-2009) until 2011Incidence of type 2 diabetes, on basis of self-reported physician diagnosis, fasting plasma glucose ≥ 7.0 mmol/l or HbA1c ≥ 6.5%

Secondary

MeasureTime frameDescription
Fish and polyunsaturated fatty acids intakeFrom entry into the study (baseline: 1997-2009) until 2011Cumulative averages of fish and PUFA intake based on 3-day 24-hr recall in each wave

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026